Publication | Closed Access

Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts

NanomedicinePolymer-drug ConjugateMedicineBreast CancerNano-drug DeliveryTumor TargetingPharmacologyRadiation Oncology